To test whether the enhanced IGF-1R signaling promotes the survival of these JQ-1 treated cells, we evaluated the growth inhibitory effect of JQ-1, BMS-754807 (a potent inhibitor of IGF-1R), and the combination of JQ-1 with BMS-754807 on SCLC cell lines. Here, IGF1R is linked to small cell lung carcinoma.